Pancreatic Steatosis as a Risk Factor for Pancreatic Ductal Adenocarcinoma: Pathogenesis and Clinical Implications

被引：1

作者：

Papalamprakopoulou, Zoi ^{[1
,2
]}

Dey, Prasenjit ^{[3
]}

Frascati, Rachel ^{[4
]}

Fountzilas, Christos ^{[2
]}

机构：

[1] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Med, Div Gastroenterol Hepatol & Nutr, Buffalo, NY 14260 USA

[2] Roswell Pk Comprehens Canc Ctr, Dept Med, Div Gastrointestinal Med Oncol, Buffalo, NY USA

[3] Roswell Pk Comprehens Canc Ctr, Dept Immunol, Buffalo, NY USA

[4] Roswell Pk Comprehens Canc Ctr, Strategy Business Dev & Outreach, Buffalo, NY USA

来源：

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY | 2025年 / 16卷 / 06期

关键词：

pancreatic steatosis; fatty pancreas; pancreatic ductal adenocarcinoma; pancreatic cancer; surveillance; risk factors; ECTOPIC FAT ACCUMULATION; COMPUTED-TOMOGRAPHY; OXIDATIVE STRESS; ADIPOSE-TISSUE; LIVER-DISEASE; CANCER; OBESITY; INFLAMMATION; IRON; INFILTRATION;

D O I：

10.14309/ctg.0000000000000832

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Pancreatic steatosis is defined as the ectopic accumulation of fat in the pancreas. While historically considered a benign incidental imaging finding, it is now recognized as a significant and potentially reversible risk factor for pancreatic ductal adenocarcinoma (PDAC) independent of obesity. Although its epidemiology is not well characterized, meta-analysis data suggest an approximately 30% prevalence, with individual studies reporting even higher rates among patients with obesity and/or metabolic syndrome. Concurrently, PDAC incidence is rising and is projected to soon become the second leading cause of cancer-related deaths. Given the critical importance of early PDAC detection and intervention for improving survival, it is particularly timely to explore the associations between pancreatic steatosis and PDAC. This review aims to provide a comprehensive overview of the pathogenesis and clinical associations between pancreatic steatosis and PDAC and to discuss future perspectives within the context of current PDAC surveillance practices.

引用

页数：10

共 137 条

[1] Decreased CT-number in the pancreatic parenchyma is a reliable imaging biomarker of the presence of malignancies in patients with high-risk intraductal papillary mucinous neoplasm [J].

Abe, Tomoki ;

Yamada, Daisaku ;

Asukai, Kei ;

Hasegawa, Shinichiro ;

Tomokuni, Akira ;

Wada, Hiroshi ;

Fujii, Wataru ;

Ikezawa, Kenji ;

Fukutake, Nobuyasu ;

Ohkawa, Kazuyoshi ;

Shinno, Naoki ;

Hara, Hisashi ;

Yanagimoto, Yoshitomo ;

Takahashi, Yusuke ;

Sugimura, Keijiro ;

Yamamoto, Kazuyoshi ;

Ushigome, Hajime ;

Haraguchi, Naotsugu ;

Nishimura, Junichi ;

Yasui, Masayoshi ;

Omori, Takeshi ;

Miyata, Hiroshi ;

Ohue, Masayuki ;

Yano, Masahiko ;

Sakon, Masato ;

Takahashi, Hidenori .

PANCREATOLOGY, 2020, 20 (03) :442-447

[2] The significance of ferritin in cancer: Anti-oxidation, inflammation and tumorigenesis [J].

Alkhateeb, Ahmed A. ;

Connor, James R. .

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1836 (02) :245-254

[3] The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study [J].

Allen, Alina M. ;

Hicks, Stephen B. ;

Mara, Kristin C. ;

Larson, Joseph J. ;

Therneau, Terry M. .

JOURNAL OF HEPATOLOGY, 2019, 71 (06) :1229-1236

[4] Lipomatous Pseudohypertrophy of the Pancreas A Clinicopathologically Distinct Entity [J].

Altinel, Deniz ;

Basturk, Olca ;

Sarmiento, Juan M. ;

Martin, Diego ;

Jacobs, Michael J. ;

Kooby, David A. ;

Adsay, N. Volkan .

PANCREAS, 2010, 39 (03) :392-397

[5] A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment [J].

Apte, Minoti V. ;

Wilson, Jeremy S. ;

Lugea, Aurelia ;

Pandol, Stephen J. .

GASTROENTEROLOGY, 2013, 144 (06) :1210-1219

[6] AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review [J].

Aslanian, Harry R. ;

Lee, Jeffrey H. ;

Canto, Marcia Irene .

GASTROENTEROLOGY, 2020, 159 (01) :358-362

[7] Adipose tissue, obesity and adipokines: role in cancer promotion [J].

Booth, Andrea ;

Magnuson, Aaron ;

Fouts, Josephine ;

Foster, Michelle .

HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2015, 21 (01) :57-74

[8] Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium [J].

Bosetti, C. ;

Rosato, V. ;

Li, D. ;

Silverman, D. ;

Petersen, G. M. ;

Bracci, P. M. ;

Neale, R. E. ;

Muscat, J. ;

Anderson, K. ;

Gallinger, S. ;

Olson, S. H. ;

Miller, A. B. ;

Bueno-de-Mesquita, H. Bas ;

Scelo, G. ;

Janout, V. ;

Holcatova, I. ;

Lagiou, P. ;

Serraino, D. ;

Lucenteforte, E. ;

Fabianova, E. ;

Ghadirian, P. ;

Baghurst, P. A. ;

Zatonski, W. ;

Foretova, L. ;

Fontham, E. ;

Bamlet, W. R. ;

Holly, E. A. ;

Negri, E. ;

Hassan, M. ;

Prizment, A. ;

Cotterchio, M. ;

Cleary, S. ;

Kurtz, R. C. ;

Maisonneuve, P. ;

Trichopoulos, D. ;

Polesel, J. ;

Duell, E. J. ;

Boffetta, P. ;

La Vecchia, C. .

ANNALS OF ONCOLOGY, 2014, 25 (10) :2065-2072

[9] Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+Cancer Cells in Locally Advanced Pancreatic Cancer [J].

Boucher, Yves ;

Posada, Jessica M. ;

Subudhi, Sonu ;

Kumar, Ashwin S. ;

Rosario, Spencer R. ;

Gu, Liqun ;

Kumra, Heena ;

Mino-Kenudson, Mari ;

Talele, Nilesh P. ;

Duda, Dan G. ;

Fukumura, Dai ;

Wo, Jennifer Y. ;

Clark, Jeffrey W. ;

Ryan, David P. ;

Fernandez-Del Castillo, Carlos ;

Hong, Theodore S. ;

Pittet, Mikael J. ;

Jain, Rakesh K. .

CLINICAL CANCER RESEARCH, 2023, 29 (08) :1605-1619

[10] KRAS: feeding pancreatic cancer proliferation [J].

Bryant, Kirsten L. ;

Mancias, Joseph D. ;

Kimmelman, Alec C. ;

Der, Channing J. .

TRENDS IN BIOCHEMICAL SCIENCES, 2014, 39 (02) :91-100

← 1 2 3 4 5 6 7 8 9 10 →